JPMorgan Chase & Co. Sells 586,929 Shares of Mirion Technologies, Inc. $MIR

JPMorgan Chase & Co. lowered its holdings in Mirion Technologies, Inc. (NYSE:MIR) by 71.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 238,340 shares of the company’s stock after selling 586,929 shares during the period. JPMorgan Chase & Co.’s holdings in Mirion Technologies were worth $5,544,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Thrivent Financial for Lutherans bought a new position in shares of Mirion Technologies during the third quarter valued at approximately $4,182,000. Rhumbline Advisers boosted its holdings in Mirion Technologies by 91.1% in the third quarter. Rhumbline Advisers now owns 608,834 shares of the company’s stock valued at $14,161,000 after acquiring an additional 290,232 shares in the last quarter. Louisiana State Employees Retirement System purchased a new position in Mirion Technologies during the 3rd quarter valued at $2,438,000. New York State Teachers Retirement System bought a new position in Mirion Technologies in the 3rd quarter worth $1,269,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Mirion Technologies by 76.8% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 417,790 shares of the company’s stock worth $9,718,000 after purchasing an additional 181,450 shares during the period. 78.51% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on MIR. Robert W. Baird cut their target price on shares of Mirion Technologies from $29.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday. Citigroup lowered their price objective on shares of Mirion Technologies from $32.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, February 12th. The Goldman Sachs Group cut their price objective on Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Morgan Stanley reduced their target price on Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating on the stock in a report on Wednesday, March 11th. Finally, Melius Research upgraded Mirion Technologies to a “strong-buy” rating in a research note on Monday, March 23rd. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Mirion Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $27.25.

Mirion Technologies Stock Up 0.5%

NYSE:MIR opened at $18.69 on Thursday. The firm’s 50-day moving average price is $21.66 and its 200-day moving average price is $23.75. The company has a market capitalization of $4.68 billion, a PE ratio of 169.89 and a beta of 1.09. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.83 and a quick ratio of 2.34. Mirion Technologies, Inc. has a 1-year low of $12.00 and a 1-year high of $30.28.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.01). Mirion Technologies had a net margin of 3.11% and a return on equity of 6.97%. The business had revenue of $277.40 million for the quarter, compared to analysts’ expectations of $281.17 million. During the same period last year, the business earned $0.17 earnings per share. The company’s revenue was up 9.1% on a year-over-year basis. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. On average, equities analysts predict that Mirion Technologies, Inc. will post 0.39 EPS for the current fiscal year.

Mirion Technologies Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.